Company / Revenue per Share
Imunon, Inc. Revenue per Share History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.01
FY2023
5-year range
$0.01 / $0.18
FY2019-FY2023
Trend
-93.3%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share has fluctuated over the past 7 years, ranging from $0.01 in FY2023 to $0.18 in FY2021.
Based on SEC 10-K filings.
0.01 in FY2023 with a 5-year CAGR of -27.6%.
Declined from $0.18 to $0.01 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -35.5%
- 5-Year CAGR
- -27.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, revenue per share decreased 93.3% year-over-year.
- Peak revenue per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $0.01 | -93.3% |
| FY2022 | $0.09 | -53.0% |
| FY2021 | $0.18 | +757.1% |
| FY2020 | $0.02 | -19.0% |
| FY2019 | $0.03 | -8.3% |
| FY2018 | $0.03 | +362.7% |
| FY2015 | $0.01 | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026